Alonso DF - Search Results

1

Soluble factors released by the target organ enhance the urokinase-type plasminogen activator activity of metastatic tumor cells.

Bal de Kier Joffé E, Alonso DF, Puricelli L. Bal de Kier Joffé E, et al. Among authors: alonso df. Clin Exp Metastasis. 1991 Jan-Feb;9(1):51-6. doi: 10.1007/BF01831709. Clin Exp Metastasis. 1991. PMID: 2015717

2

[Role of plasminogen activators in cancer dissemination. Clinical perspectives].

Alonso DF, Bal de Kier Joffé E. Alonso DF, et al. Medicina (B Aires). 1992;52(3):252-6. Medicina (B Aires). 1992. PMID: 1342692 Review. Spanish. No abstract available.

3

Effect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinoma.

Puricelli L, Gómez DE, Vidal MC, Eiján AM, Spinelli O, Alonso DF, de Lustig ES, Bal de Kier Joffé E. Puricelli L, et al. Among authors: alonso df. Tumour Biol. 1994;15(5):284-93. doi: 10.1159/000217903. Tumour Biol. 1994. PMID: 7991989 Free article.

4

Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas.

Alonso DF, Farías EF, Bal de Kier Joffé E. Alonso DF, et al. Cancer Lett. 1993 Jul 16;70(3):181-7. doi: 10.1016/0304-3835(93)90229-3. Cancer Lett. 1993. PMID: 8353814

5

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.

Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihgtt AR, Charreau EH, Elizalde PV. Guerra FK, et al. Among authors: alonso df. Int J Cancer. 1996 Mar 15;65(6):812-20. doi: 10.1002/(SICI)1097-0215(19960315)65:6<812::AID-IJC18>3.0.CO;2-5. Int J Cancer. 1996. PMID: 8631597

6

Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.

Alonso DF, Farías EF, Urtreger A, Ladeda V, Vidal MC, Bal De Kier Joffé E. Alonso DF, et al. J Surg Oncol. 1996 Aug;62(4):288-97. doi: 10.1002/(SICI)1096-9098(199608)62:4<288::AID-JSO14>3.0.CO;2-1. J Surg Oncol. 1996. PMID: 8691844

7

Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementia.

Alonso DF, Farias EF, Famulari AL, Dominguez RO, Kohan S, de Lustig ES. Alonso DF, et al. J Neurol Sci. 1996 Jul;139(1):83-8. J Neurol Sci. 1996. PMID: 8836977

8

Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.

Alonso DF, Farías EF, Ladeda V, Davel L, Puricelli L, Bal de Kier Joffé E. Alonso DF, et al. Breast Cancer Res Treat. 1996;40(3):209-23. doi: 10.1007/BF01806809. Breast Cancer Res Treat. 1996. PMID: 8883963

9

Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.

Aguirre Ghiso JA, Alonso DF, Farías EF, Bal de Kier Joffé E. Aguirre Ghiso JA, et al. Among authors: alonso df. Biochim Biophys Acta. 1997 Apr 24;1356(2):171-84. doi: 10.1016/s0167-4889(96)00173-5. Biochim Biophys Acta. 1997. PMID: 9150275 Free article.

10

A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f-actin and beta1-integrin point contact distribution.

Aguirre Ghiso JA, Farías EF, Alonso DF, Arregui C, Bal de Kier Joffé E. Aguirre Ghiso JA, et al. Among authors: alonso df. Int J Cancer. 1997 May 29;71(5):881-90. doi: 10.1002/(sici)1097-0215(19970529)71:5<881::aid-ijc29>3.0.co;2-9. Int J Cancer. 1997. PMID: 9180160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters